68Ga-DOTATATE PET/MRI for Neuroendocrine Tumors: A Pictorial Review

Nghi C. Nguyen, Chan Hong Moon, Ashok Muthukrishnan, Alessandro Furlan

Research output: Contribution to journalArticlepeer-review

3 Scopus citations


Neuroendocrine tumors (NETs) constitute a variety of neoplastic entities and exhibit variable degrees of neuroendocrine differentiation and phenotypes, as well as genetic profiles. 68Ga-DOTATATE PET is a novel imaging technique for NET. Although PET/CT is commonly utilized for oncologic imaging, PET/MRI is particularly suited for NETs, as MRI provides greater soft tissue contrast than CT, allowing for improved detection and characterization of NETs, particularly when liver metastasis is suspected or needs to be ruled out. The current pictorial review aims to illustrate the complementary advantages, as well as pitfalls of 68Ga-DOTATATE PET/MRI in the evaluation of NETs.

Original languageEnglish (US)
Pages (from-to)E406-E410
JournalClinical nuclear medicine
Issue number9
StatePublished - Sep 1 2020
Externally publishedYes


  • PET/CT
  • neuroendocrine tumors

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging


Dive into the research topics of '68Ga-DOTATATE PET/MRI for Neuroendocrine Tumors: A Pictorial Review'. Together they form a unique fingerprint.

Cite this